Supplementary Data from DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody–Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models Article Swipe

View

Michiko Yamato , Jun Hasegawa , Takanori Maejima , Chiharu Hattori , Kazuyoshi Kumagai , Akiko Watanabe , Yumi Nishiya , Tomoko Shibutani , Tetsuo Aida , Ichiro Hayakawa , Takashi Nakada , Yuki Abe , Toshinori Agatsuma ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1535-7163.22521898

Supplementary Data from DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody–Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models

Related Topics

Mathematical Analysis

Mathematics

Concepts

Conjugate Drug Topoisomerase Antibody-drug conjugate Antibody Pharmacology Medicine Cancer research DNA Biology Immunology Monoclonal antibody Genetics Mathematical analysis Mathematics

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1535-7163.22521898
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4362489382

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4362489382

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1535-7163.22521898

Digital Object Identifier
Title: Supplementary Data from DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody–Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-04-03

Full publication date if available
Authors: Michiko Yamato, Jun Hasegawa, Takanori Maejima, Chiharu Hattori, Kazuyoshi Kumagai, Akiko Watanabe, Yumi Nishiya, Tomoko Shibutani, Tetsuo Aida, Ichiro Hayakawa, Takashi Nakada, Yuki Abe, Toshinori Agatsuma

List of authors in order
Landing page: https://doi.org/10.1158/1535-7163.22521898

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1535-7163.22521898

Direct OA link when available
Concepts: Conjugate, Drug, Topoisomerase, Antibody-drug conjugate, Antibody, Pharmacology, Medicine, Cancer research, DNA, Biology, Immunology, Monoclonal antibody, Genetics, Mathematical analysis, Mathematics

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4362489382
doi	https://doi.org/10.1158/1535-7163.22521898
ids.doi	https://doi.org/10.1158/1535-7163.22521898
ids.openalex	https://openalex.org/W4362489382
fwci
type	preprint
title	Supplementary Data from DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody–Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11845
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9993000030517578
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1312
topics[0].subfield.display_name	Molecular Biology
topics[0].display_name	Cancer therapeutics and mechanisms
topics[1].id	https://openalex.org/T10755
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.996399998664856
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	HER2/EGFR in Cancer Research
topics[2].id	https://openalex.org/T12827
topics[2].field.id	https://openalex.org/fields/13
topics[2].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[2].score	0.9940999746322632
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/1312
topics[2].subfield.display_name	Molecular Biology
topics[2].display_name	Biochemical and Molecular Research
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C197336794
concepts[0].level	2
concepts[0].score	0.7569019198417664
concepts[0].wikidata	https://www.wikidata.org/wiki/Q5161150
concepts[0].display_name	Conjugate
concepts[1].id	https://openalex.org/C2780035454
concepts[1].level	2
concepts[1].score	0.6361836194992065
concepts[1].wikidata	https://www.wikidata.org/wiki/Q8386
concepts[1].display_name	Drug
concepts[2].id	https://openalex.org/C147897179
concepts[2].level	3
concepts[2].score	0.587207019329071
concepts[2].wikidata	https://www.wikidata.org/wiki/Q407828
concepts[2].display_name	Topoisomerase
concepts[3].id	https://openalex.org/C2777325958
concepts[3].level	4
concepts[3].score	0.564230740070343
concepts[3].wikidata	https://www.wikidata.org/wiki/Q1069596
concepts[3].display_name	Antibody-drug conjugate
concepts[4].id	https://openalex.org/C159654299
concepts[4].level	2
concepts[4].score	0.5098999738693237
concepts[4].wikidata	https://www.wikidata.org/wiki/Q79460
concepts[4].display_name	Antibody
concepts[5].id	https://openalex.org/C98274493
concepts[5].level	1
concepts[5].score	0.46717649698257446
concepts[5].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[5].display_name	Pharmacology
concepts[6].id	https://openalex.org/C71924100
concepts[6].level	0
concepts[6].score	0.3761870861053467
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[6].display_name	Medicine
concepts[7].id	https://openalex.org/C502942594
concepts[7].level	1
concepts[7].score	0.3722134828567505
concepts[7].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[7].display_name	Cancer research
concepts[8].id	https://openalex.org/C552990157
concepts[8].level	2
concepts[8].score	0.34997284412384033
concepts[8].wikidata	https://www.wikidata.org/wiki/Q7430
concepts[8].display_name	DNA
concepts[9].id	https://openalex.org/C86803240
concepts[9].level	0
concepts[9].score	0.24800735712051392
concepts[9].wikidata	https://www.wikidata.org/wiki/Q420
concepts[9].display_name	Biology
concepts[10].id	https://openalex.org/C203014093
concepts[10].level	1
concepts[10].score	0.19709500670433044
concepts[10].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[10].display_name	Immunology
concepts[11].id	https://openalex.org/C542903549
concepts[11].level	3
concepts[11].score	0.1545875072479248
concepts[11].wikidata	https://www.wikidata.org/wiki/Q422248
concepts[11].display_name	Monoclonal antibody
concepts[12].id	https://openalex.org/C54355233
concepts[12].level	1
concepts[12].score	0.1448427438735962
concepts[12].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[12].display_name	Genetics
concepts[13].id	https://openalex.org/C134306372
concepts[13].level	1
concepts[13].score	0.0
concepts[13].wikidata	https://www.wikidata.org/wiki/Q7754
concepts[13].display_name	Mathematical analysis
concepts[14].id	https://openalex.org/C33923547
concepts[14].level	0
concepts[14].score	0.0
concepts[14].wikidata	https://www.wikidata.org/wiki/Q395
concepts[14].display_name	Mathematics
keywords[0].id	https://openalex.org/keywords/conjugate
keywords[0].score	0.7569019198417664
keywords[0].display_name	Conjugate
keywords[1].id	https://openalex.org/keywords/drug
keywords[1].score	0.6361836194992065
keywords[1].display_name	Drug
keywords[2].id	https://openalex.org/keywords/topoisomerase
keywords[2].score	0.587207019329071
keywords[2].display_name	Topoisomerase
keywords[3].id	https://openalex.org/keywords/antibody-drug-conjugate
keywords[3].score	0.564230740070343
keywords[3].display_name	Antibody-drug conjugate
keywords[4].id	https://openalex.org/keywords/antibody
keywords[4].score	0.5098999738693237
keywords[4].display_name	Antibody
keywords[5].id	https://openalex.org/keywords/pharmacology
keywords[5].score	0.46717649698257446
keywords[5].display_name	Pharmacology
keywords[6].id	https://openalex.org/keywords/medicine
keywords[6].score	0.3761870861053467
keywords[6].display_name	Medicine
keywords[7].id	https://openalex.org/keywords/cancer-research
keywords[7].score	0.3722134828567505
keywords[7].display_name	Cancer research
keywords[8].id	https://openalex.org/keywords/dna
keywords[8].score	0.34997284412384033
keywords[8].display_name	DNA
keywords[9].id	https://openalex.org/keywords/biology
keywords[9].score	0.24800735712051392
keywords[9].display_name	Biology
keywords[10].id	https://openalex.org/keywords/immunology
keywords[10].score	0.19709500670433044
keywords[10].display_name	Immunology
keywords[11].id	https://openalex.org/keywords/monoclonal-antibody
keywords[11].score	0.1545875072479248
keywords[11].display_name	Monoclonal antibody
keywords[12].id	https://openalex.org/keywords/genetics
keywords[12].score	0.1448427438735962
keywords[12].display_name	Genetics
language	en
locations[0].id	doi:10.1158/1535-7163.22521898
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1535-7163.22521898
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5052059964
authorships[0].author.orcid
authorships[0].author.display_name	Michiko Yamato
authorships[0].author_position	first
authorships[0].raw_author_name	Michiko Yamato
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5040913051
authorships[1].author.orcid	https://orcid.org/0000-0002-0489-6065
authorships[1].author.display_name	Jun Hasegawa
authorships[1].author_position	middle
authorships[1].raw_author_name	Jun Hasegawa
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5007073256
authorships[2].author.orcid	https://orcid.org/0000-0003-1295-6504
authorships[2].author.display_name	Takanori Maejima
authorships[2].author_position	middle
authorships[2].raw_author_name	Takanori Maejima
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5027685554
authorships[3].author.orcid
authorships[3].author.display_name	Chiharu Hattori
authorships[3].author_position	middle
authorships[3].raw_author_name	Chiharu Hattori
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5077821372
authorships[4].author.orcid	https://orcid.org/0000-0003-4974-939X
authorships[4].author.display_name	Kazuyoshi Kumagai
authorships[4].author_position	middle
authorships[4].raw_author_name	Kazuyoshi Kumagai
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5073602207
authorships[5].author.orcid	https://orcid.org/0000-0001-7496-5911
authorships[5].author.display_name	Akiko Watanabe
authorships[5].author_position	middle
authorships[5].raw_author_name	Akiko Watanabe
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5039811057
authorships[6].author.orcid	https://orcid.org/0009-0008-5806-8696
authorships[6].author.display_name	Yumi Nishiya
authorships[6].author_position	middle
authorships[6].raw_author_name	Yumi Nishiya
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5086993429
authorships[7].author.orcid	https://orcid.org/0000-0002-6991-6610
authorships[7].author.display_name	Tomoko Shibutani
authorships[7].author_position	middle
authorships[7].raw_author_name	Tomoko Shibutani
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5109602298
authorships[8].author.orcid
authorships[8].author.display_name	Tetsuo Aida
authorships[8].author_position	middle
authorships[8].raw_author_name	Tetsuo Aida
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5050775905
authorships[9].author.orcid	https://orcid.org/0000-0003-2749-9078
authorships[9].author.display_name	Ichiro Hayakawa
authorships[9].author_position	middle
authorships[9].raw_author_name	Ichiro Hayakawa
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5010381887
authorships[10].author.orcid
authorships[10].author.display_name	Takashi Nakada
authorships[10].author_position	middle
authorships[10].raw_author_name	Takashi Nakada
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5035406837
authorships[11].author.orcid	https://orcid.org/0000-0002-5352-724X
authorships[11].author.display_name	Yuki Abe
authorships[11].author_position	middle
authorships[11].raw_author_name	Yuki Abe
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5019088691
authorships[12].author.orcid	https://orcid.org/0000-0001-7319-9442
authorships[12].author.display_name	Toshinori Agatsuma
authorships[12].author_position	last
authorships[12].raw_author_name	Toshinori Agatsuma
authorships[12].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1535-7163.22521898
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Data from DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody–Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11845
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9993000030517578
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1312
primary_topic.subfield.display_name	Molecular Biology
primary_topic.display_name	Cancer therapeutics and mechanisms
related_works	https://openalex.org/W2893386726, https://openalex.org/W2047893495, https://openalex.org/W2400412854, https://openalex.org/W2097697790, https://openalex.org/W2020684201, https://openalex.org/W1954622523, https://openalex.org/W2100049223, https://openalex.org/W2094941924, https://openalex.org/W4362530235, https://openalex.org/W4214766446
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1535-7163.22521898
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1535-7163.22521898
primary_location.id	doi:10.1158/1535-7163.22521898
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1535-7163.22521898
publication_date	2023-04-03
publication_year	2023
referenced_works_count	0
abstract_inverted_index.I	7
abstract_inverted_index.a	4
abstract_inverted_index.in	18
abstract_inverted_index.DNA	5
abstract_inverted_index.Data	1
abstract_inverted_index.from	2
abstract_inverted_index.B7-H3,	13
abstract_inverted_index.Exerts	14
abstract_inverted_index.Models	20
abstract_inverted_index.Potent	15
abstract_inverted_index.Antitumor	16
abstract_inverted_index.Conjugate	11
abstract_inverted_index.DS-7300a,	3
abstract_inverted_index.DXd-Based	9
abstract_inverted_index.Targeting	12
abstract_inverted_index.Activities	17
abstract_inverted_index.Inhibitor,	8
abstract_inverted_index.Preclinical	19
abstract_inverted_index.Supplementary	0
abstract_inverted_index.Topoisomerase	6
abstract_inverted_index.Antibody–Drug	10
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	13
citation_normalized_percentile.value	0.17270231
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False